Mahamaya Lifesciences IPO Description – Established in 2002, Mahamaya Lifesciences is a leading manufacturer of pesticide formulations, supplying bulk formulations to Indian agrochemical companies and multinational corporations. Initially focused on importing and registering vital pesticide molecules not produced in India, the company secured approvals from the Central Insecticides Board and Registration Committee (CIBRC) before marketing these molecules domestically and internationally.
In December 2021, Mahamaya commissioned its formulation plant at Dahej, Gujarat, enabling production of bulk formulations, branded products, and exports. Domestically, its 300+ dealer network spans Punjab, Haryana, Rajasthan, Uttar Pradesh, Gujarat, and Maharashtra, while exports reach countries such as the Dominican Republic, Turkey, Egypt, and the UAE.
As of 30 June 2025, the company offer diverse product range including 136 insecticide products, 71 fungicide products, 58 herbicide products, 9 bio-stimulants/Plant Growth Regulators, 3 biopesticides and 1 Biofertilizers. As of 30 September 2025, Mahamaya employs 78 staff and maintains flexible contract labor to meet operational needs, reinforcing its strong domestic and global market presence.
Promoters of Mahamaya Lifesciences – Mr. Krishnamurthy Ganesan, Mrs. Lalitha Krishnamurthy, and Mr. Prashant Krishnamurthy
Table of Contents
Mahamaya Lifesciences Offer Details
| Mahamaya Lifesciences IPO Dates | 11 – 13 November 2025 |
| Mahamaya Lifesciences Issue Price | INR 108 – 114 per share |
| Fresh Issue | 56,38,800 shares (INR 60.90 – 64.28 crore) |
| Offer For Sale | 5,40,000 shares (INR 5.83 – 6.16 crore) |
| Total IPO Size | 61,78,800 shares (INR 66.73 – 70.44 crore) |
| Minimum Bid | 2,400 shares (INR 2,73,600) |
| Lot Size | 1,200 shares (INR 1,36,800) |
| Face Value | INR 10 per share |
| Individual Allocation | 35% |
| Listing On | BSE SME |
Mahamaya Lifesciences Financial Performance
| FY 2023 | FY 2024 | FY 2025 | Q1 FY 2026 | |
| Revenue | 137.08 | 161.57 | 264.15 | 83.01 |
| Expenses | 132.30 | 155.71 | 249.81 | 78.35 |
| Net income | 3.75 | 5.22 | 12.94 | 4.10 |
Mahamaya Lifesciences Offer News
- Mahamaya Lifesciences RHP
- Mahamaya Lifesciences Draft Prospectus
- ASBA IPO Forms
- Live IPO Subscription Status
- Highest SME IPO Subscription in 2025
Mahamaya Lifesciences Valuations & Margins
| FY 2023 | FY 2024 | FY 2025 | |
| EPS | 2.34 | 3.26 | 7.60 |
| PE ratio | – | – | 14.21 – 15.0 |
| RONW (%) | 19.29 | 21.16 | 26.19 |
| NAV | 12.13 | 15.38 | 27.82 |
| ROCE (%) | 20.00 | 16.16 | 23.15 |
| EBITDA (%) | 6.49 | 8.20 | 9.22 |
Mahamaya Lifesciences IPO GMP Today
| Date | Consolidated IPO GMP | Kostak | Subject to Sauda |
| Coming soon | – | – | – |
Mahamaya Lifesciences IPO Subscription – Live Updates
| Category | QIB | NII | Individual | Total |
|---|---|---|---|---|
| Shares Offered | 11,76,000 | 8,82,000 | 20,59,200 | 41,17,200 |
| 13 Nov 2025 | 1.19 | 3.99 | 1.02 | 1.71 |
| 12 Nov 2025 | 0.65 | 0.62 | 0.20 | 0.42 |
| 11 Nov 2025 | 0.00 | 0.35 | 0.07 | 0.11 |
The market maker reservation portion of 3,09,600 shares and the anchor investor portion of 17,52,000 shares are not included in the above calculations.
Mahamaya Lifesciences IPO Allotment Status
Mahamaya Lifesciences IPO allotment status is now available on the KFin Tech website. Click on this link to get the allotment status.
Mahamaya Lifesciences IPO Dates & Listing Performance
| IPO Opening Date | 11 November 2025 |
| IPO Closing Date | 13 November 2025 |
| Finalization of Basis of Allotment | 14 November 2025 |
| Initiation of refunds | 17 November 2025 |
| Transfer of shares to demat accounts | 17 November 2025 |
| IPO Listing Date | 18 November 2025 |
| Opening Price on BSE SME | INR 116 per share (up 1.75%) |
| Closing Price on BSE SME | INR 116 per share (up 1.75%) |
Mahamaya Lifesciences Offer Lead Manager
ONEVIEW CORPORATE ADVISORS PRIVATE LIMITED
Bajaj Bhawan, Room No. 111, 11th Floor,
Nariman Point, Mumbai – 400021
Phone: +91- 22- 43472247
Email: [email protected]
Website: www.oneviewadvisors.com
Mahamaya Lifesciences Offer Registrar
KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Tel: +91 40 6716 2222
E-mail: [email protected]
Website: www.kfintech.com
Mahamaya Lifesciences Contact Details
MAHAMAYA LIFESCIENCES LIMITED
Unit No: DPT – 033, Ground Floor,
Plot No: 79 – 80, DLF Prime Tower, F-Block,
Okhla, Phase – 1, New Delhi – 110020
Phone: +91-1146561474
E-mail: [email protected]
Website: www.mahamayalifesciences.com
IPO FAQs
What is the Mahamaya Lifesciences’ offer size?
Mahamaya Lifesciences’ offer size is INR 66.73 – 70.44 crores.
What is the Mahamaya Lifesciences’ offer price band?
Mahamaya Lifesciences public offer price is INR 108 – 114 per share.
What is the lot size of the Mahamaya Lifesciences IPO?
Mahamaya Lifesciences offer lot size is 1,200 shares.
What is the Mahamaya Lifesciences IPO GMP today?
Mahamaya Lifesciences IPO GMP today is INR NA per share.
What is the Mahamaya Lifesciences kostak rate today?
Mahamaya Lifesciences kostak rate today is INR NA per application.
What is the Mahamaya Lifesciences IPO Subject to Sauda rate today?
Mahamaya Lifesciences Subject to Sauda rate today is INR NA per application.